martes, 1 de septiembre de 2015

Hepatology, Medicine and Policy

Hepatology, Medicine and Policy

Hepatology, Medicine and Policy

Jeffrey V. Lazarus

Jeffrey V. Lazarus is a senior researcher at CHIP, the Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He is also a professor at the Lithuanian University of Health Sciences, Medical Academy, an affiliated professor at the Institute of Public Health, University of Porto and a member of the Centre for Health and Social Change at the London School of Hygiene and Tropical Medicine. His decade-long career as a health systems and communicable diseases expert at WHO’s Regional Office for Europe was followed by a stint at the Global Fund to Fight AIDS, Tuberculosis and Malaria, where he led knowledge translation. In 2012, he became the co-founding secretariat director of Health Systems Global and a steering committee member of the Correlation Network HCV Initiative. He now serves as the Board Chair of the AIDS Foundation East-West (AFEW), a steering committee member of the European Commission’s new joint action on HIV and hepatitis, and a section editor of BMC Health Services Research.

Associate Editors

  • Rakesh Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India
  • Evaldo Araujo, International Hepatitis Society, Brazil
  • Ann-Sofie Duberg, Örebro University, Sweden
  • Philippa Easterbrook, World Health Organization, Switzerland
  • Jordan Feld, University of Toronto, Canada
  • Angelos Hatzakis, Athens University Medical School, Greece
  • Margaret E Hellard, Burnet Institute Melbourne, Australia
  • Vivian Hope, Public Health England, United Kingdom
  • Dyfed Wyn Huws, Public Health Wales, United Kingdom
  • Stefan Mauss, Center for HIV and Hepatogastroenterology, Germany
  • Antons Mozalevskis, World Health Organization, Denmark
  • Mark Nelson, NHS, United Kingdom
  • Lars Peters, University of Copenhagen, Denmark
  • Mika M. Salminen, National Institute for Health and Welfare (THL), Finland
  • Joan Tallada, University of Barcelona, Spain
  • Tengiz Tsertsvadze, Tbilisi State University, Georgia
  • Heiner Wedemeyer, Hannover Medical School, Germany
  • Lucas Wiessing, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal

Editorial Board Members

  • Alessio Aghemo, Fondazione IRCCS Ospedale Maggiore, Italy
  • Sanjay Bhagani, Royal Free Hospital and UCL, London, United Kingdom
  • Henry Chang, Actavis Consulting Group, LLC, United States of America
  • Graham Cooke, Imperial College London, United Kingdom
  • Kevin A Fenton, Public Health England, United Kingdom
  • Hernan Fuenzalida-Puelma, The World Progress Center, United States of America
  • Fiona Godfrey, European Association for the Study of the Liver, Luxembourg
  • Charles Gore, World Hepatitis Alliance, United Kingdom
  • Magdalena Harris, London School of Hygiene and Tropical Medicine, United Kingdom
  • Achim Kautz, European Liver Patients Association, Germany
  • Michel Kazatchkine, Université René Descartes, France
  • Svilen Konov, European AIDS Treatment Group, Belgium
  • Ludmila Maistat, International HIV/AIDS Alliance in Ukraine, Ukraine
  • Michael Ninburg, Hepatitis Education Project, United States of America
  • Raquel Peck, World Hepatitis Alliance, United Kingdom
  • Juergen Rockstroh, University Hospital of Bonn, Germany
  • Anders Sonnerborg, Karolinska Institut, Sweden
  • Heino Stover, University of Applied Sciences, Germany
  • Emilis Subata, Vilnius University, Lithuania
  • Tracy Swan, Treatment Action Group, United States of America
  • Peter Vickerman, University of Bristol, United Kingdom
  • Matthew Weait, Birkbeck, University of London, United Kingdom
  • Stefan Wiktor, World Health Organization, Switzerland

Hepatology, Medicine and Policy
Submit a manuscriptEditorial BoardAuthor InstructionsArticle Alerts
I am delighted to announce that our new open access journal Hepatology, Medicine and Policy is now open for submissions.
Aims and Scope
Hepatology, Medicine and Policy seeks to situate biomedical advances in hepatology within the broader political and social context that determines the ultimate impact of research in both resource-rich and resource-limited settings. The journal emphasises the translation of evidence into action, in part by encouraging the authors of original research articles to present their findings in ways that are meaningful to policy-makers, advocates and community members.
Why do we need a new hepatology journal? – Blog
As we celebrated the 5th World Hepatitis Day on the 28th of July, we reflected on the progress in combating this group of diseases. It was also an opportunity to ask what more needs to be done. Editor-in-Chief Jeffrey V. Lazarus tells us why the journal fills an important gap in hepatology research. Read the full blog post.
Do you have a new study to publish?
Hepatology, Medicine and Policy (HMAP) considers articles on the prevention and management of viral and non-viral hepatitis and other liver disorders, including articles on the public health, policy and biomedical dimensions of these conditions.
-Affiliated to the World Hepatitis Alliance
-Authors retain copyright of their work
-All articles are open access: universally accessible online without charge
World Hepatitis Alliance
Our author instructions with guide you through the submission process, but do not hesitate to contact us for any editorial enquiries.
Kind regards,
Jeffrey V. Lazarus
Editor-in-Chief, Hepatology, Medicine and Policy
P.S. Stay up-to-date: sign up for article alerts
Hepatology, Medicine and Policy

No hay comentarios: